26707881 | Inhibition of BRD4 suppresses tumor growth and enhances iodine uptake in thyroid cancer. | Biochem Biophys Res Commun | 2016 Jan 15 | Gao X | doi: 10.1016/j.bbrc.2015.12.008 |
25284786 | Transformation resistance in a premature aging disorder identifies a tumor-protective function of BRD4. | Cell Rep | 2014 Oct 9 | Fernandez P | doi: 10.1016/j.celrep.2014.08.069 |
28073847 | Identification of CCR2 and CD180 as Robust Pharmacodynamic Tumor and Blood Biomarkers for Clinical Use with BRD4/BET Inhibitors. | Clin Cancer Res | 2017 Feb 15 | Yeh TC | doi: 10.1158/1078-0432.CCR-16-1658 |
26752646 | CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer. | J Clin Invest | 2016 Feb | McCleland ML | doi: 10.1172/JCI83265 |
24646477 | Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle. | Nat Commun | 2014 Mar 19 | Lamoureux F | doi: 10.1038/ncomms4511. |
25647019 | BRD4 promotes pancreatic ductal adenocarcinoma cell proliferation and enhances gemcitabine resistance. | Oncol Rep | 2015 Apr | Wang YH | doi: 10.3892/or.2015.3774 |
27099234 | BRD4 Connects Enhancer Remodeling to Senescence Immune Surveillance. | Cancer Discov | 2016 Jun | Tasdemir N | doi: 10.1158/2159-8290.CD-16-0217 |
28100396 | Small molecules remain on target for c-Myc. | Elife | 2017 Jan 19 | Sun L | doi: 10.7554/eLife.22915. |
27440272 | Bromodomain and Extraterminal Protein Inhibitor JQ1 Suppresses Thyroid Tumor Growth in a Mouse Model. | Clin Cancer Res | 2017 Jan 15 | Zhu X | doi: 10.1158/1078-0432.CCR-16-0914 |
30308518 | Bromodomain-Containing Protein 4 (BRD4) Inhibition Sensitizes Palomid 529-Induced Anti-Renal Cell Carcinoma Cell Activity in Vitro and in Vivo. | Cell Physiol Biochem | 2018 | Xing ZY | doi: 10.1159/000494185 |
26840017 | High level of BRD4 promotes non-small cell lung cancer progression. | Oncotarget | 2016 Feb 23 | Liao YF | doi: 10.18632/oncotarget.7068. |
27769352 | Phospho-BRD4: transcription plasticity and drug targeting. | Drug Discov Today Technol | 2016 Mar | Chiang CM | doi: 10.1016/j.ddtec.2016.05.003 |
28681984 | BRD4 promotes gastric cancer progression through the transcriptional and epigenetic regulation of c-MYC. | J Cell Biochem | 2018 Jan | Ba M | doi: 10.1002/jcb.26264 |
30036377 | BRD4 amplification facilitates an oncogenic gene expression program in high-grade serous ovarian cancer and confers sensitivity to BET inhibitors. | PLoS One | 2018 Jul 23 | Rhyasen GW | doi: 10.1371/journal.pone.0200826 |
24525235 | Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer. | Cancer Cell | 2014 Feb 10 | Shi J | doi: 10.1016/j.ccr.2014.01.028. |
26626481 | NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler. | Mol Cell | 2015 Dec 17 | Shen C | doi: 10.1016/j.molcel.2015.10.033 |
22120039 | Aberrant epigenetic regulation of bromodomain BRD4 in human colon cancer. | J Mol Med (Berl) | 2012 May | Rodriguez RM | doi: 10.1007/s00109-011-0837-0 |
19846528 | Abrogation of the Brd4-positive transcription elongation factor B complex by papillomavirus E2 protein contributes to viral oncogene repression. | J Virol | 2010 Jan | Yan J | doi: 10.1128/JVI.01647-09. |
25892415 | Histo-genomic stratification reveals the frequent amplification/overexpression of CCNE1 and BRD4 genes in non-BRCAness high grade ovarian carcinoma. | Int J Cancer | 2015 Oct 15 | Goundiam O | doi: 10.1002/ijc.29568 |
25506891 | Twist-BRD4 complex: potential drug target for basal-like breast cancer. | Curr Pharm Des | 2015 | Shi J | - |
27084101 | BET Inhibition Attenuates Helicobacter pylori-Induced Inflammatory Response by Suppressing Inflammatory Gene Transcription and Enhancer Activation. | J Immunol | 2016 May 15 | Chen J | doi: 10.4049/jimmunol.1502261 |
29133261 | Dual inhibition of BRD4 and PI3K by SF2523 suppresses human prostate cancer cell growth invitro and invivo. | Biochem Biophys Res Commun | 2018 Jan 1 | Shen G | doi: 10.1016/j.bbrc.2017.11.062 |
27259267 | BET inhibition as a new strategy for the treatment of gastric cancer. | Oncotarget | 2016 Jul 12 | Montenegro RC | doi: 10.18632/oncotarget.9766. |
28766687 | Downregulation of BRD4 inhibits gallbladder cancer proliferation and metastasis and induces apoptosis via PI3K/AKT pathway. | Int J Oncol | 2017 Sep | Hao J | doi: 10.3892/ijo.2017.4081 |
30029633 | Tumoral BRD4 expression in lymph node-negative breast cancer: association with T-bet+ tumor-infiltrating lymphocytes and disease-free survival. | BMC Cancer | 2018 Jul 20 | Lee M | doi: 10.1186/s12885-018-4653-6. |
30272279 | Inhibition of BRD4 suppresses tumor growth in prostate cancer via the enhancement of FOXO1 expression. | Int J Oncol | 2018 Dec | Tan Y | doi: 10.3892/ijo.2018.4577 |
30057199 | DUB3 Promotes BET Inhibitor Resistance and Cancer Progression by Deubiquitinating BRD4. | Mol Cell | 2018 Aug 16 | Jin X | doi: 10.1016/j.molcel.2018.06.036 |